Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · ZOTA

Zota Health Care Ltd

HealthcarePharmaceuticals & Biotechnology₹4552 cr market cap
₹1306.00 ▼ -0.65% today As of 19 Nov 2026
52-week low ₹1028.1052-week high ₹1687.00

-22.1% from the 52-week high · +27.9% above the low

Zota Health Care Ltd. engages in the manufacture, sale and export of pharmaceutical products. The company is headquartered in Surat, Gujarat. The company went IPO on 2017-05-10. The firm manufactures, markets, and exports pharmaceutical, ayurvedic, nutraceutical, and over the counter (OTC) products. The Company’s business model comprises three verticals, namely Domestic, Exports and Retail Pharmacy Chain (Davaindia). Its Marketing business vertical involves the direct distribution of generic drugs, OTC products, and other pharmaceutical products through the Company’s distribution network across India. The company has a portfolio of more than 3,000 products in various categories, such as generics, OTC products, allopathic, ayurvedic and others. In the Retail Pharmacy Chain business vertical, it operates a chain of pharmacy stores under the brand Davaindia. Its domestic products include AMLOTOZ AT Tab, APIXACEED 2.5 Tab, APIXACEED 5 Tab, ATRONA 10 Tab, ATRONA 20 Tab, ATRONA 40 Tab, ATRONA ASP 75 Cap, ATRONA ASP 150 Cap, ATRONA ASP 20/75 Cap, ATRONA FB Tab and others.

The short version. Zota Health Care Ltd reported revenue of ₹199 crore for Sep 2026, up 54.3% from a year earlier. Net profit was ₹-26 crore. Return on equity was -10.7% in Mar 2026. Promoter holding was 49.38% in Sep 2026, down 12.64 points over 8 quarters.

1 · The price

How has the stock traded?

Zota Health Care Ltd trades 22.1% below its 52-week high and 27.9% above its 52-week low.

Change over period: —

1M-3.3%
3M+17.9%
6M+9.3%
1Y-16.5%

2 · The business

Is it growing?

Sales, year on year+54.3%

Sep 2026 revenue of ₹199 cr.

Net margin-12.8%

0.4 pts lower than a year earlier.

3-year growth134.0% profit

Revenue compounded at 56.7% over the same 3 years.

Reported results · ₹ crore

Revenue and profit

Show the numbers

Quarterly

Sep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue1991741631431291049772
Net profit-26-44-14-30-16-14-13-19
Net margin %-12.8-25.1-8.7-20.6-12.4-13.8-13.3-25.9
EPS (₹)-7.39-12.58-4.09-8.74-5.2-4.81-4.5-6.78

Annual

FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Revenue53929318014013110795
Net profit-74-56-14-6903
Net margin %-13.7-19.3-7.9-4.16.8-0.22.9
EPS (₹)-21.35-19.7-5.55-2.293.54-0.091.12

3 · The quality

How well does it turn capital into profit?

Return on equity was -10.7% in Mar 2026; debt to equity is 0.04.

Profitability · 4 years

Returns and margins

Mar 2026Mar 2025Mar 2024Mar 2023
Return on equity %-10.7-25.2-16.0-7.2
Return on capital %-7.0-13.8-7.4-1.8
EBITDA margin %3.7-1.24.86.9
Net margin %-13.5-19.1-7.9-4.1

Compound growth

Revenue vs profit

3 years5 years
Revenue CAGR56.7%38.3%
Profit CAGR134.0%223.4%
Debt to equity0.04
Interest cover-3.6x
Current ratio1.93

4 · The owners

Who holds it, and are they adding?

Promoter holding49.38%

Down 12.64 pts over 8 quarters.

Foreign institutions6.92%

Up 6.68 pts over 8 quarters.

Domestic institutions7.3%

Up 6.27 pts over 8 quarters.

Mutual fund schemes2

+2 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter62.0259.7257.4255.8150.6449.3849.3849.38-12.64
FII0.240.873.823.498.098.217.926.92+6.68
DII1.033.084.254.957.226.46.757.3+6.27
Public36.7136.3334.5235.7534.0636.035.9636.4-0.31

Mutual fund holdings · Oct 2026

2 schemes hold this stock

0 the month before.

  • WhiteOak Capital Special Opportunities Fund0.54% of NAV
  • WhiteOak Capital Pharma and Healthcare Fund0.4% of NAV

See what mutual funds are buying

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for Zota Health Care Ltd are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about Zota Health Care Ltd

What is the Zota Health Care Ltd share price?

Zota Health Care Ltd (ZOTA) last closed at ₹1,306.00, down 0.65% on the day. Its 52-week range is ₹1,028.10 to ₹1,687.00.

What is the market cap of Zota Health Care Ltd?

Zota Health Care Ltd has a market capitalisation of about ₹4,552 crore.

How are Zota Health Care Ltd's latest results?

Zota Health Care Ltd reported revenue of ₹199 crore for Sep 2026, up 54.3% from a year earlier. Net profit was ₹-26 crore. Return on equity was -10.7% in Mar 2026. Promoter holding was 49.38% in Sep 2026, down 12.64 points over 8 quarters.

Who owns Zota Health Care Ltd?

As of Sep 2026, shareholding was: Promoter 49.38%, FII 6.92%, DII 7.3%, Public 36.4%.

How many mutual funds hold Zota Health Care Ltd?

2 mutual fund schemes held Zota Health Care Ltd in October 2026. That compares with 0 the month before.

Corporate actions

Recent dividends, bonuses and splits

  • 22 Sep 2025 · Dividend - Rs. 1
  • 20 Sep 2024 · Dividend - Rs. 1
  • 22 Sep 2023 · Dividend - Rs. 1
  • 19 Sep 2022 · Dividend - Rs. 1.5
  • 22 Sep 2021 · Dividend - Rs. 1
  • 17 Sep 2020 · Dividend - Rs. 1

Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.